Reduction of Prep1 Levels Affects Differentiation of Normal and Malignant B Cells and Accelerates Myc Driven Lymphomagenesis

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Iotti, Giorgio ^a   Mejetta, Stefania ^a   Modica, Livia ^a   Penkov, Dmitry ^b   Ponzoni, Maurilio ^c   Blasi, Francesco ^a  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; IMMUNOGLOBULIN M; PROTEIN PREP1; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE DIFFERENTIATION; CARCINOGENESIS; CONTROLLED STUDY; GENE; HAPLOINSUFFICIENCY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; ONCOGENE MYC; PRE B LYMPHOCYTE; PREP1 GENE;

ALLELES; ANIMALS; ANTIGENS, CD45; APOPTOSIS; B-LYMPHOCYTES; CELL PROLIFERATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HAPLOINSUFFICIENCY; HOMEODOMAIN PROTEINS; IMMUNOPHENOTYPING; LOSS OF HETEROZYGOSITY; LYMPHOCYTES; LYMPHOMA, B-CELL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-MYC; REAL-TIME POLYMERASE CHAIN REACTION;

MUS;

EID: 84868139457     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048353     Document Type: Article

References (23)

1. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, et al. (1985) The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318: 533-538.
2. Wen R, Chen Y, Bai L, Fu G, Schuman J, et al. (2006) Essential role of phospholipase C gamma 2 in early B-cell development and Myc-mediated lymphomagenesis. Mol Cell Biol 26: 9364-9376.
3. Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL, (1999) Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 13: 2658-2669.
4. Schmitt CA, McCurrach ME, de Stanchina E, Wallace-Brodeur RR, Lowe SW, (1999) INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev 13: 2670-2677.
5. Gorrini C, Squatrito M, Luise C, Syed N, Perna D, et al. (2007) Tip60 is a haploinsufficient tumor suppressor required for an oncogene-induced DNA damage response. Nature 448: 1063-1067.
6. Mori S, Rempel RE, Chang JT, Yao G, Lagoo AS, et al. (2008) Utilization of pathway signatures to reveal distinct types of B lymphoma in the Eμ-myc model and human diffuse large B-cell lymphoma. Cancer Res 68: 8525-8534.
7. Longobardi E, Iotti G, Di Rosa P, Mejetta S, Bianchi F, et al. (2010) Prep1 (pKnox1)-deficiency leads to spontaneous tumor development in mice and accelerates EμMyc lymphomagenesis: A tumor suppressor role for Prep1. Mol Oncol 4: 126-134.
8. Fernandez-Diaz LC, Laurent A, Girasoli S, Turco M, Longobardi E, et al. (2010) The absence of Prep1 causes p53-dependent apoptosis of mouse pluripotent epiblast cells. Development 137: 3393-3403.
9. Ferretti E, Villaescusa JC, Di Rosa P, Fernandez-Diaz LC, Longobardi E, et al. (2006) Hypomorphic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype. Mol Cell Biol 26: 5650-5662.
10. Iotti G, Longobardi E, Masella S, Dardaei L, De Santis F, et al. (2011) Homeodomain transcription factor and tumor suppressor Prep1 is required to maintain genomic stability. Proc Natl Acad Sci U S A 108: E314-322.
11. Di Rosa P, Villaescusa JC, Longobardi E, Iotti G, Ferretti E, et al. (2007) The homeodomain transcription factor Prep1 (pKnox1) is required for hematopoietic stem and progenitor cell activity. Dev Biol 311: 324-334.
12. Degnan BM, Vervoort M, Larroux C, Richards GS, (2009) Early evolution of metazoan transcription factors. Curr Opin Genet Dev 19: 591-599.
13. DiMartino JF, Selleri L, Traver D, Firpo MT, Rhee J, et al. (2001) The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver. Blood 98: 618-626.
14. Sanyal M, Tung JW, Karsunky H, Zeng H, Selleri L, et al. (2007) B-cell development fails in the absence of the Pbx1 proto-oncogene. Blood 109: 4191-4199.
15. Ficara F, Murphy MJ, Lin M, Cleary ML, (2008) Pbx1 regulates self-renewal of long-term hematopoietic stem cells by maintaining their quiescence. Cell Stem Cell 2: 484-496.
16. Hisa T, Spence SE, Rachel RA, Fujita M, Nakamura T, et al. (2004) Hematopoietic, angiogenic and eye defects in Meis1 mutant animals. EMBO J 23: 450-459.
17. Azcoitia V, Aracil M, Martínez-A C, Torres M, (2005) The homeodomain protein Meis1 is essential for definitive hematopoiesis and vascular patterning in the mouse embryo. Dev Biol 280: 307-320.
18. Penkov D, Di Rosa P, Fernandez Diaz L, Basso V, Ferretti E, et al. (2005) Involvement of Prep-1 in the alpha-betaTCR T-lymphocytic potential of hematopoietic precursors. Mol Cell Biol 25: 10768-10781.
19. van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, et al. (1991) Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging. Cell 65: 737-752.
20. Hardy RR, Hayakawa K, (2001) B cell development pathways. Annu Rev Immunol 19: 595-621.
21. Nepal RM, Tong L, Kolaj B, Edelmann W, Martin A, (2009) Msh2-dependent DNA repair mitigates a unique susceptibility of B cell progenitors to c-Myc-induced lymphomas. Proc Natl Acad Sci U S A 106: 18698-18703.
22. Hameyer D, Loonstra A, Eshkind L, Schmitt S, Antunes C, et al. (2007) Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues. Physiol Genomics 31: 32-41.
23. Rowan S, Siggers T, Lachke SA, Yue Y, Bulyk ML, et al. (2010) Precise temporal control of the eye regulatory gene Pax6 via enhancer-binding site affinity. Genes Dev. 24: 980-985.